Beneficial Exposome Study
Launched by STANFORD UNIVERSITY · Oct 16, 2023
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
The Beneficial Exposome Study is a research project that aims to understand how regular exposure to natural compounds might help improve our overall health. These compounds are found in everyday plants and could have positive effects on our bodies. By studying how these substances influence health, researchers hope to uncover new ways to promote wellness.
To join this study, participants need to be at least 18 years old, able to read and understand English, and currently living in the U.S. However, certain individuals cannot participate, such as those who are pregnant, breastfeeding, or have specific health conditions like epilepsy or allergies to certain plants. If you decide to take part, you can expect to help researchers learn more about the benefits of these natural compounds and how they affect our health. This study is currently looking for volunteers, so it’s a great opportunity to contribute to important health research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years of age and older
- • Read, speak, and understand English
- • Live in the US territory
- Exclusion Criteria:
- • Mental incapacity and/or cognitive impairment on the part of the patient that would preclude adequate understanding of, or cooperation with, the study protocol
- • Is pregnant
- • Is breastfeeding
- • Has epilepsy
- • Has allergies to Cupressaceae family of plants, common plants include redwoods, junipers, cypress, cedar, fir, and sequoia
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palo Alto, California, United States
Patients applied
Trial Officials
Michael Snyder, PhD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported